Exome

Whole Exome Sequencing (WES) targets the protein-coding regions of the genome, where most disease-causing mutations are found.

With over 7,000 rare diseases identified—80% of which have a genetic basis—WES offers a powerful approach to uncover their causes.

Traditional diagnostic methods can be slow, costly, and inconclusive; WES streamlines the process by delivering broad genetic insights in a single test.

Operify Exome enhances WES by combining comprehensive coverage with advanced interpretation, improving diagnostic yield and patient outcomes.